Antibacterial activity of AuNPs in some studies^a.

Nanocomposites	Bacteria	Synthesis method	Application	Ref.
AuNPs	Staphylococcus aureus and Pseudomonas aeruginosa	Green synthesis method	Environmental/biological	57
UsAuNPs/MOFs hybrid	S. aureus and E. coli	Hydrothermal	Wound healing, clinical	94
Au, Ag, and Pd nanoparticles-carbon composite	Gram-negative bacterial strains	Green synthesis method	Electrochemical energy storage applications	59
MnFe2O4@SiO2@Au	P. aeruginosa, Klebsiella pneumoniae and Proteus mirabilis bacteria	Ultrasound-assisted precipitation	Treatment of bacterial and fungal diseases	61
Au@Bi2S3	S. aureus and E. coli	Schottky junction via intermediate layer conversion method	Environmental remedy and medical treatment	62
PDMS-ZnO/Au	E. coli	Photo-reduction protocol/hydrothermal	Biological contamination for catheter, medical paint, and implant tools	63
AuNPs-COOH/AgNO3	E. coli and S. aureus	Seeding method	Nanomedicine engineering	64
TNTs/Au/CDs	S. aureus and E. coli	NA	Public health and medical disinfection	65
Ag–Au/CeO2	S. aureus and E. coli strains	Ionic liquid functionalized green synthesized	Biological	66
Au–Pt	E. coli, P. aeruginosa, K. pneumoniae, and Salmonella choleraesuis	Co-reduction	Clinical	67
Titania/TiO2	E. coli	Hydrothermal method	Marine antifouling paint sewage and treatment	68
Au/TiO2	Bacillus subtilis	NA	Biological	69
Fe3O4–Au NCs	Gram-positive and Gram-negative pathogens	Reduction method	Water samples, pharmaceutical and medical applications	70
CML@X-NPs, X = Ag, Au	S. aureus, Enterococcus faecalis, P. aeruginosa, Acinebacter baumannii, E. coli, K. pneumoniae and P. mirabilis	Green synthesis	Biological, clinical	71
ZMS-Au	S. aureus and E. coli strains	Layer-by-layer self-assembly	Environmental protection	72
Au@TiO2-NT	S. aureus	NA	Orthopedic devices and implants	73
Propane-1,2,3-triol and Ag/AuNPs	E. coli and Staphylococcus epidermidis	Size-controlled synthesis	Environmental	74
Au/Ag alloy nanoparticles using Coleus aromaticus	S. aureus and E. coli	NA	Biological fields	75
GO@Au@Ag	E. coli	NA	Environmental	76
GPA NPs	Biofilms and intracellular bacteria	Green synthesis	Treatment of chronic infections	77
Watermelon extract-AuNPs	E. coli and S. epidermidis	Biogenic synthesis	Pharmaceutical applications	78
Au/TiO2	E. coli	Solvothermal method	Biological fields	79
Trimetallic Au/Pt/Ag	Some microorganisms	Chemical reduction method	Pharmaceutical applications, environmental and medical	80
TiO2–Au	Bacterial adhesion and biofilm	NA	Orthopedic and dental implants	81
Silicone-Au-Mb	E. coli and S. epidermidis	Swell-encapsulation-shrink	NA	82
Cellulose paper-Au-AgNPs	E. coli	NA	Wound dressings, food packaging, personal care products and clothing	83
TiO2@ZnO	Candida albicans, S. aureus and E. coli	NA	Biological applications	84
LPB-AuNPs	Gram-positive and 4 Gram-negative bacterial strains	NA	Biological applications	85
Aragonite-AuNPs	Gram-negative e.g., Pseudomonas putida (P. putida), anti-biofilm	Hydrothermal synthesis	Medical application	86
CS–AuNPs	Methicillin–resistant S. aureus	Co-reduction	Medical application	87
(α-Fe2O3)-AuNPs	E. coli	Hydrothermal	Wastewater remediation applications	88
Ag/AuNPs	S. aureus and E. coli	Citrate-capped nanoparticle synthesis	Biological, clinical	89
Ag/AuNPs	Antibiotic-resistant bacteria and C. albicans	Green synthesis	Pharmaceutical applications, environmental and medical	90
AuNPs	Enterobacter cloacae, Staphylococcus haemolyticus and Staphylococcus petrasii	Green synthesis	Cell line studies, pharmaceutical applications	91
Ag/Pt, Ag/Ir, Ag/PtIr, Au/Pt, Au/Ir, and Au/PtIr	S. epidermidis, S. aureus, Streptococcus pyogenes, P. aeruginosa and Enterococcus faecium	MOCVD	Pharmaceutical and medical applications	92
AuNPs-EGCG	S. aureus, E. faecalis, P. aeruginosa and E. coli	Green synthesis	Biomedical and biological	93

^aNA: not available, (UsAuNPs/MOFs hybrid): ultra-small AuNPs/metal–organic frameworks, (PDMS-ZnO/Au): polydimethylsiloxane, (Fe₃O₄–Au NCs): iron oxide gold nanocomposites, (CML@X-NPs, X = Ag, Au): Crataegus monogyna leaf extract with gold nanoparticles, (LPB): lipopeptide biosurfactant, (CS–AuNPs): chitosan–gold hybrid nanoparticles, (MOCVD): metal–organic chemical vapor deposition, (EGCG): epigallocatechin 3-gallate.